The
rules on breaking down large packs of paracetamol into smaller packs has been
relaxed in light of supply shortages during the Covid-19 pandemic.
Pharmacists
are now permitted to split packs of the medication up in order to sell them in
smaller quantities over the counter, after the RPS sought clarification from
the GPhC.
Related Article: ‘Little capacity’ to deliver NHS reforms without primary care investment
Pharmacy
staff have been encouraged by RPS to ‘prioritise
people who need medicines rather than rules around licensing or packaging over
their care,’ when faced with professional dilemmas.
The
organisation assured pharmacists they will support their professional judgement
but warned staff they must be prepared to justify some of their decisions.
The
body suggested pharmacies ‘risk assess’ situations, ‘make a record of the intervention in the PMR and
check [that they’ve] got the right bulk pack, name, quantity, ingredients,
expiry date and batch number’.
They also told pharmacies to decide upon
a ‘quantity that’s appropriate for the person needing it’ and make sure the
‘labeling for that new quantity is correct’ and includes everything a typical
medication label would.
Related Article: Pharmacy First could help reduce AMR, suggests report
Pharmacies are also told to ‘print and
supply a patient information leaflet from electronic medicines compendium
(emc)’.
The RPS also warned that it will not support
excessive pricing, in light of some pharmacies inflating prices of common drugs
like paracetamol as customers continue to panic buy.
The move comes as 80 medicines, including paracetamol, have been banned
from parallel export, to ensure a consistent supply for UK patients who
need them during the coronavirus pandemic.
Related Article: OBE award the ‘pinnacle of my career’ says community pharmacist
Earlier this month, The Pharmacist
reported that pharmacy wholesalers
had run out of paracetamol and ibuprofen leaving community pharmacies
struggling to restock.
The full RPS guidance on splitting packs of paracetamol
is available here.
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.